Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus

Vaccine

Volumn 19, Issue 27, 2001, Pages 3661-3670

  Langeveld, Jan P M ^a   Brennan, Frank R ^b   Martínez Torrecuadrada, Jorge L ^c   Jones, Tim D ^b   Boshuizen, Ronald S ^a   Vela, Carmen ^c   Casal, J Ignacio ^c   Kamstrup, Søren ^d   Dalsgaard, Kristian ^e   Meloen, Rob H ^a   Bendig, Mary M ^b   Hamilton, William D O ^b,f  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Axis Genetics plc   (United Kingdom)

^c Inmunologia y Genetica Aplicada SA   (Spain)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Proteom Ltd   (United Kingdom)

Author keywords

Canine parvovirus; Chimaeric plant virus

Indexed keywords

ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; PEPTIDE VP2; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOG; DRUG EFFECT; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; PARVOVIRUS; PLANT VIRUS; PRIORITY JOURNAL; SURVIVAL; ULTRAVIOLET RADIATION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS SHEDDING;

AMINO ACID SEQUENCE; ANIMALS; CAPSID; CAPSID PROTEINS; COMOVIRUS; DOG DISEASES; DOGS; IMMUNIZATION SCHEDULE; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; RECOMBINANT PROTEINS; ULTRAVIOLET RAYS; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0035859281     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00083-4     Document Type: Article

References (41)

1. The expression of hybrid HIV:ty virus-like particles in yeast
2. Nasal delivery of vaccines
3. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
4. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice
5. A chimeric plant virus vaccine protects against bacterial infection
6. Pseudomonas aeruginosa outer membrane protein F epitopes are highly immunogenic when expressed on a plant virus
7. Immunogenicity of peptides derived from a fibronectin-binding protein (FnBP) of S. aureus expressed on two different plant viruses
8. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate
9. Peptide vaccine against canine parvovirus: Identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence
10. The autonomously replicating parvoviruses of vertebrates
11. Plant-derived vaccine protects target animals against a viral disease
12. Mucosal adjuvants
13. Live Salmonella vaccines as a route towards oral immunisation
14. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid
15. Adjuvants for human vaccines-current status, problems and future prospects
16. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunisation
17. DNA vaccines: Safety and efficacy issues
18. First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs
19. Full protection in mink against enteritis virus with new generation canine parvovrius vaccines based on synthetic peptide or recombinant protein
20. Recombinant vaccine for canine parvovirus in dogs
21. Fine-mapping of canine parvovirus B cell epitopes
22. PEPSCAN to determine T and B cell epitopes
23. Efficacy of an inactivated virus vaccine for prevention of porcine parvovirus-induced reproductive failure
24. Pathogenesis of canine parvovirus enteritis: The importance of viremia
25. Protein expression in vivo by injection of polynucleotides
26. Infectious process of the parvovirus H-1: Correlation of protein content, particle density and viral infectivity
27. Emergence, natural history and variation of canine, mink and feline parvoviruses
28. The emergence and evolution of canine parvovirus-an example of recent host range mutation
29. Development of cowpea moasic virus as a high-yielding system for the presentation of foreign peptides
30. Multiple antigen constructs (MACs): Induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii
31. Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV1) V3 loop seroprevalence library induce neutralizing responses against HIV-1
32. The use of enzyme-linked immunosorbent assays for serology and antigen detection in canine parvovirus infections
33. Poliovirus antigen chimeras
34. Detection of cow pea mosaic virus (CPMV) by reverse transcriptase polymerase chain reaction (RT-PCR)
35. Characteristics and taxononmy of Parvoviridae
36. Non-replicating vaccinia vector efficiently expresses recombinant genes
37. Expression of an animal virus antigenic on the surface of a plant virus particle
38. Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapie
39. Recurrent thrombocytopenic purpura after repeated measles/mumps/rubella vaccination
40. Potential use of live viral and bacterial vectors for vaccines